Short-course neoadjuvant in situ vaccination for murine melanoma

por Aiken, Taylor J, Komjathy, David, Rodriguez, Matthew, Stuckwisch, Ashley, Feils, Arika, Subbotin, Vladimir, Birstler, Jen, Gillies, Stephen D, Rakhmilevich, Alexander L, Erbe, Amy K, Sondel, Paul M
Publicado 2022

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist

por Pieper, Alexander A., Spiegelman, Dan V., Felder, Mildred A. R., Feils, Arika S., Tsarovsky, Noah W., Zaborek, Jen, Morris, Zachary S., Erbe, Amy K., Rakhmilevich, Alexander L., Sondel, Paul M.
Publicado 2023

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

por Feils, A. S., Erbe, A. K., Birstler, J., Kim, K., Hoch, U., Currie, S. L., Nguyen, T., Yu, D., Siefker-Radtke, A. O., Tannir, N., Tolaney, S. M., Diab, A., Sondel, P. M.
Publicado 2023

Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma

por Aiken, Taylor J, Erbe, Amy K, Zebertavage, Lauren, Komjathy, David, Feils, Arika S, Rodriguez, Matthew, Stuckwisch, Ashley, Gillies, Stephen D, Morris, Zachary S, Birstler, Jen, Rakhmilevich, Alexander L, Sondel, Paul M
Publicado 2022

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy

por Hoefges, A, McIlwain, SJ, Erbe, AK, Mathers, N, Xu, A, Melby, D, Tetreault, K, Le, T, Kim, K, Pinapati, RS, Garcia, B, Patel, J, Heck, M, Feils, AS, Tsarovsky, N, Hank, JA, Morris, ZS, Ong, IM, Sondel, PM
Publicado 2023

Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination

por Carlson, Peter M, Patel, Ravi B, Birstler, Jen, Rodriquez, Matthew, Sun, Claire, Erbe, Amy K, Bates, Amber M, Marsh, Ian, Grudzinski, Joseph, Hernandez, Reinier, Pieper, Alexander A, Feils, Arika S, Rakhmilevich, Alexander L, Weichert, Jamey P, Bednarz, Bryan P, Sondel, Paul M, Morris, Zachary S
Publicado 2023

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group

por Erbe, Amy K, Diccianni, Mitch B, Mody, Rajen, Naranjo, Arlene, Zhang, Fan F, Birstler, Jen, Kim, KyungMann, Feils, Arika S, Hung, Jung-Tung, London, Wendy B, Shulkin, Barry L, Mathew, Varsha, Parisi, Marguerite T, Servaes, Sabah, Asgharzadeh, Shahab, Maris, John M, Park, Julie, Yu, Alice L, Sondel, Paul M, Bagatell, Rochelle
Publicado 2023

Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models

por Pieper, Alexander A., Zangl, Luke M., Speigelman, Dan V., Feils, Arika S., Hoefges, Anna, Jagodinsky, Justin C., Felder, Mildred A., Tsarovsky, Noah W., Arthur, Ian S., Brown, Ryan J., Birstler, Jen, Le, Trang, Carlson, Peter M., Bates, Amber M., Hank, Jacquelyn A., Rakhmilevich, Alexander L., Erbe, Amy K., Sondel, Paul M., Patel, Ravi B., Morris, Zachary S.
Publicado 2021